INVEST RADIO:ASL在早产儿神经发育评估中的应用

2022-07-12 shaosai MedSci原创

动脉自旋标记(ASL)是一个可以量化大脑发育的功能MRI序列。

近年来,随着新生儿护理的改善,越来越多的早产新生儿在出生后得以存活下来。然而,全球新生儿的早产率约为11%,这些新生儿的护理已成为世界范围内的一个主要健康问题。早产新生儿很容易出现神经,因此建立提示早产新生儿发育障碍的早期生物标志物越来越重要

动脉自旋标记(ASL)一个可以量化大脑发育的功能MRI序列。研究表明,用ASL测量的区域CBF可用于量化新生儿的大脑成熟度。与年龄较大的儿童相比,新生儿的CBF较低、血流速度较低、大脑体积较小、血液和脑组织的弛豫时间不同,因此限制了ASL应用。

T1和T2弛豫时间是MRI特有的测量方法,反映了脑组织的内在属性,是另一种有前途的MRI定量工具。由于髓鞘是由不同的生化物质组成的,脑组织的特性会根据髓鞘的程度而改变。使用多回波和多延时饱和恢复自旋回波序列的合成MRI研究显示了儿童组织属性随年龄的变化。

近日,发表在INVEST RADIO杂志的一项研究探讨了早产新生儿的早期CBF和弛豫时间与神经发育结果的相关性,为临床评估早产儿神经系统发育情况并对发育异常的早产儿进行早期干预提供了影像学支持。

项前瞻性研究招募早产新生儿在2017年9月-2018年12月期间进行了动脉自旋标记和合成MRI成像。这些新生儿在18个月大时接受了Bayley婴儿发展量表测试,并对认知和运动结果评分进行了测量。测量了不同脑区的校正CBF以及T1和T2弛豫时间值。测量值与出生时的胎龄(GA)和MRI扫描时的校正GA相关联。对测量值和神经发育结果评分进行了简单和多元线性回归分析。 

49名新生儿(中位数[四分位数范围]GA,30[2]周,209[17]天;28名男孩)在足月或接近足月时进行了MRI扫描(中位数[四分位数范围]校正GA,37[2]周,258[14]天)。CBF(系数,0.31-0.59)和弛豫时间(系数,-0.39至-0.86)值显示与校正的GA有明显的相关性,但与GA没有相关性。控制GA后,早产新生儿的额叶白质CBF与认知结果评分呈负相关(β = -0.97; P = 0.029)。控制GA后,额叶白质T1弛豫时间与认知结果评分呈正相关(β = 0.03; P = 0.025)。 


图 两个早产新生儿的合成T1WI、合成T2WI、T1弛豫时间图、T2弛豫时间图和tCBF图,这两个新生儿都没有看到明确的WM结构异常。一个MDI评分为118分的早产新生儿显示额部WM tCBF为每分钟10毫升/10克,T1弛豫时间为2790毫秒(A)。一个MDI得分较低的83岁早产儿显示出相对较高的额叶WM tCBF,为每分钟12毫升/100克,T1弛豫时间较短,为2704毫秒(B)

本研究表明,早产新生儿的CBF和T1弛豫时间与新生儿的认知结果有关。尽管有出生时具有GA的混杂影响,但额部WM的CBF和T1弛豫时间与18个月矫正年龄的认知评分有明显的关系。其他区域的CBF或弛豫时间值与神经发育结果没有明显的相关性。本研究发现表明,反映额叶WM加速成熟的较高CBF和较低T1弛豫时间与不良的认知结果有关。

 

原文出处:

Hyun Gi Kim,Jin Wook Choi,Jang Hoon Lee,et al.Association of Cerebral Blood Flow and Brain Tissue Relaxation Time With Neurodevelopmental Outcomes of Preterm Neonates: Multidelay Arterial Spin Labeling and Synthetic MRI Study.DOI:10.1097/RLI.0000000000000833.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2051806, encodeId=7ed920518060e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Jul 20 09:34:52 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345659, encodeId=99291345659d5, content=<a href='/topic/show?id=37c9e4238b9' target=_blank style='color:#2F92EE;'>#神经发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74238, encryptionId=37c9e4238b9, topicName=神经发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347634, encodeId=f147134e634c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519277, encodeId=81aa15192e756, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2051806, encodeId=7ed920518060e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Jul 20 09:34:52 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345659, encodeId=99291345659d5, content=<a href='/topic/show?id=37c9e4238b9' target=_blank style='color:#2F92EE;'>#神经发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74238, encryptionId=37c9e4238b9, topicName=神经发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347634, encodeId=f147134e634c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519277, encodeId=81aa15192e756, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2051806, encodeId=7ed920518060e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Jul 20 09:34:52 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345659, encodeId=99291345659d5, content=<a href='/topic/show?id=37c9e4238b9' target=_blank style='color:#2F92EE;'>#神经发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74238, encryptionId=37c9e4238b9, topicName=神经发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347634, encodeId=f147134e634c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519277, encodeId=81aa15192e756, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 neurowu
  4. [GetPortalCommentsPageByObjectIdResponse(id=2051806, encodeId=7ed920518060e, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Wed Jul 20 09:34:52 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345659, encodeId=99291345659d5, content=<a href='/topic/show?id=37c9e4238b9' target=_blank style='color:#2F92EE;'>#神经发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74238, encryptionId=37c9e4238b9, topicName=神经发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347634, encodeId=f147134e634c7, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4c124, createdName=neurowu, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519277, encodeId=81aa15192e756, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Jul 13 05:34:52 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 lq1771

相关资讯

Stroke:早产儿脑静脉窦血栓形成

在患有CVST的早产儿样本中,超过四分之一的患儿是无症状的。随访时以脑白质损伤为主,一半患儿伴有神经功能缺损。在这个小群体中,CVST早产儿接受抗凝治疗似乎是安全的。

Pediatrics:音乐疗法对早产儿真的有效吗?

早产被认为是一个全球性的健康挑战, 本研究的主要目的是评价音乐治疗对母婴亲和力的影响,其次是评价MT对早产儿父母焦虑和母亲抑郁的影响。

NEJM:出生后2周开始氢化可的松治疗对改善早产儿无中重度支气管肺发育不良生存率效果不显著

对于存在支气管肺发育不良的早产儿,从出生后第14至28天开始的氢化可的松治疗不能改善无中重度支气管肺发育不良生存率,组间2年的神经发育结果也没有显著差异

Lancet子刊:早产儿成年后COPD风险增加,而吸烟会加重这些不良影响

这项研究首次探索了早产对中年期肺功能的影响。

PLOS MED:结果为阴性——阿司匹林预防复发性自发性早产的有效性评估

低剂量阿司匹林并没有显著降低曾有过自然早产的妇女的早产率。

ADCFNE:输注成年男性血浆不会改变早产儿循环中性类固醇水平

新生儿重症监护室(NICU)经常向早产儿提供新鲜冰冻血浆,但存在较大的地区差异。